BusinessAxsome Therapeutics Announces Issuance of U.S. Patent Covering AXS-02 for the Treatment of Bone Marrow Lesions of the KneeBy Nasdaq OMXJan 27, 2016, 11:30 AM UTC
BusinessFate Therapeutics Announces FDA Clearance of Investigational New Drug Application for ProTmune for Prevention of Acute GvHD and CMV InfectionBy Nasdaq OMXJan 26, 2016, 9:36 PM UTC
BusinessMetabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016By Nasdaq OMXJan 26, 2016, 9:05 PM UTC
BusinessNovavax Prices $300 Million of Convertible Senior Notes Due 2023By Nasdaq OMXJan 26, 2016, 1:01 AM UTC
BusinessGENETHERA SECURES NEW LABORATORY FACILITIES TO EXPAND TECHNOLOGY PLATFORMSBy Nasdaq OMXJan 25, 2016, 5:34 PM UTC
BusinessAmedica Enhances Valeo II™ Product Family With the Addition of Its Second Generation Cervical SystemBy Nasdaq OMXJan 25, 2016, 1:30 PM UTC
BusinessNovavax Announces Proposed Offering of $200 Million of Convertible Senior Notes Due 2023By Nasdaq OMXJan 25, 2016, 12:00 PM UTC
BusinessAffimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA(R) (pembrolizumab) for Patients with Hodgkin LymphomaBy Nasdaq OMXJan 25, 2016, 10:00 AM UTC
